Key Insights

Highlights

Success Rate

60% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

12.5%

2 terminated out of 16 trials

Success Rate

60.0%

-26.5% vs benchmark

Late-Stage Pipeline

13%

2 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed with results

Key Signals

3 with results60% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (3)
P 1 (3)
P 2 (2)
P 3 (2)

Trial Status

Recruiting6
Unknown4
Completed3
Terminated2
Not Yet Recruiting1

Trial Success Rate

60.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07585643Not Yet RecruitingPrimary

IBIS - Investigating Reliability of BIS and SEDLINE Monitoring in Children With Developmental and Epileptic Encephalopathies (DEE).

NCT07019922Phase 3RecruitingPrimary

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

NCT07227857Phase 1RecruitingPrimary

A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

NCT05301894Phase 2TerminatedPrimary

Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

NCT01858285Recruiting

Genetics of Epilepsy and Related Disorders

NCT04802135RecruitingPrimary

Creation of a Register of Patients With Neonatal-onset Epileptic Encephalopathy

NCT03936777Phase 3Completed

A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome

NCT07176832Phase 1Completed

Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)

NCT04625101Phase 2CompletedPrimary

Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-827104 in Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

NCT06855901Not ApplicableRecruiting

Home Ultra-long Term EEG Monitoring for Rare Epilepsies and Developmental and Epileptic Encephalopathies

NCT05722990Recruiting

Genetic Investigations in Children With Developmental and Epileptic Encephalopathies in Ho Chi Minh City, Vietnam

NCT03934268Unknown

A Cohort Study on the Prognosis of Neonatal KCNQ2 Gene-associated Epileptic Encephalopathy

NCT03024827Phase 1UnknownPrimary

Cannabidiol in Children With Refractory Epileptic Encephalopathy

NCT03955432Not ApplicableTerminated

Long-term Cardiac Monitoring in Epilepsy

NCT04496310Not ApplicableUnknown

Tele-epic (Telemedicine for Epilepsy Care)

NCT02603991UnknownPrimary

Prospective Cohort Study on the Efficacy of Vagus Nerve Stimulation for Children and Adolescents With Epilepsy(PVNS-CAE)

Showing all 16 trials

Research Network

Activity Timeline